Rare diseases
Investigational molecules
Locations
Back to Bulgaria442 clinical trials in Plovdiv, Bulgaria across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
BulgariaA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
BulgariaBulgariaPhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
BulgariaStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
BulgariaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
BulgariaLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
BulgariaBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
BulgariaA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focuses on influenza virus prevention and hepatitis delta infection treatment. Clinical trials are evaluating new vaccine formulations and therapeutic approaches for viral infections.
Studies include testing of adjuvanted vaccines and novel antiviral medications for chronic conditions.
Research initiatives targeting hypertriglyceridemia and heart failure prevention. Studies are exploring innovative treatments for metabolic conditions and cardiovascular risk reduction.
Trials evaluate new compounds for managing metabolic disorders and preventing cardiovascular events.
Comprehensive studies on psoriatic arthritis, Sjögren's disease, and systemic sclerosis. Research focuses on innovative biological therapies and treatment approaches.
Clinical trials are investigating novel therapeutic agents for managing chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
